Vaccine clinical trials to treat and potentially prevent type 1 diabetes 28 April 2021 An oral vaccine that could treat or potentially prevent type 1 diabetes is in clinical trials at the University of Queensland. Associate Professor Emma Hamilton-Williams hopes the research will end the lifelong dependency on insulin. With the support of the Diabetes Australia Research Program researchers are aiming to create a vaccine that can re-educate the t-cells in the immune system to stop the pathogenic process that leads them to destroy the insulin-producing cells in the pancreas. You can watch the video here:
Media releases 19 August 2026 Wearable non-invasive continuous glucose monitor leads innovation challenge Xoma Labs has been named the Grand Innovation Challenge winner, following a nationwide search for innovative technologies to transform the lives of people living with diabetes. Continue Reading
Media releases 18 August 2026 500k Shane Warne Legacy Health Check milestone on the first day of international diabetes congress The Western-Pacific’s largest diabetes and metabolic health congress has opened with a Community Day in Melbourne, delivering the 500,000th Shane Warne Legacy health check to highlight the importance of cardiometabolic health screenings, and the urgent nature of the type 2 diabetes epidemic facing the region. Continue Reading
Media releases 17 August 2026 Diabetes Australia to deliver Insulin Pump Program supporting children and young people Diabetes Australia has been appointed to deliver the Commonwealth-funded Insulin Pump Program (IPP). Continue Reading